课题基金 / 基金详情

Sex as a Biological Variable Supplement - Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Sex as a Biological Variable Supplement - Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals
性别作为生物变量补充剂 - 药物再利用以快速开发和评估 SARS-CoV-2 抗病毒药物
批准号:
424698
负责人:
Côt Marceline
金额:
$2.91万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-04-01 至 2021-04-01

项目摘要

项目成果

Côt Marceline的其他基金

相似基金

相关文献

中文摘要
翻译
COVID-19的最初症状是发烧、呼吸急促和干咳。对于一些患者,随着感染扩散到肺部并导致严重炎症,疾病进展为肺炎。这些严重的症状可能会导致困难,
英文摘要
The initial symptoms of COVID-19 are fever, shortness of breath and a dry cough. For some patients, the disease progresses to pneumonia as the infection spreads to the lung and leads severe inflammation. These severe symptoms can cause difficulties for th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement of antiviral T-cell responses for improved control of viral infection
  • 批准号:
    477159
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2023
  • 负责人:
    Côt Marceline
  • 依托单位:
Characterization of filovirus host factors and small-molecule inhibitors of infection
  • 批准号:
    473350
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.64万
  • 财政年份:
    2022
  • 负责人:
    Côt Marceline
  • 依托单位:
COVID-19 Variant Supplement - Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals
  • 批准号:
    443296
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Côt Marceline
  • 依托单位:
Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals
  • 批准号:
    422711
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.28万
  • 财政年份:
    2020
  • 负责人:
    Côt Marceline
  • 依托单位:
海外基金